Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, July 12 '25)

Image
By G.M.

 


    BMJ

  1. HOUSE TA
    Pandemic response: no one is immune to getting things wrong.
    BMJ. 2025;390:r1415.
    PubMed        

  2. BHATT N
    Covid-19: Indian health ministry refutes links between sudden cardiac death and vaccination.
    BMJ. 2025;390:r1426.
    PubMed        


    Infect Control Hosp Epidemiol

  3. NEARY M, Quan K, Tjoa T, Bittencourt CE, et al
    Did universal masking during the COVID-19 pandemic reduce MRSA and MSSA acquisition in the NICU?
    Infect Control Hosp Epidemiol. 2025 Jul 11:1-6. doi: 10.1017/ice.2025.10209.
    PubMed         Abstract available


    Int J Infect Dis

  4. BERG J, Linden K, Zaigham M, Domellof M, et al
    The Association between Antenatal SARS-CoV-2 Exposure and Infant Neurodevelopment at Four Months of Age: A Prospective Multicenter Cohort Survey within the COPE Study.
    Int J Infect Dis. 2025 Jul 3:107973. doi: 10.1016/j.ijid.2025.107973.
    PubMed         Abstract available

  5. JIA Y, Zhang L, Xie Y, Hao L, et al
    Incidence of acute respiratory infections and their associated pathogen distribution among residents in Shanghai, China: Preliminary results from community-based surveillance in the 2023-24 influenza season.
    Int J Infect Dis. 2025 Jul 3:107974. doi: 10.1016/j.ijid.2025.107974.
    PubMed         Abstract available


    J Med Virol

  6. WANG H, Zhang Z, Gan M, Cui Z, et al
    Dynamics of Crossed Acquired Immunity Against SARS-CoV-2 Variants: From Vaccine to Hybrid Immunity in China.
    J Med Virol. 2025;97:e70487.
    PubMed         Abstract available

  7. VAN SLAMBROUCK J, Vos R, Etienne I, Carlier F, et al
    The Nationwide Impact of COVID-19 on Lung Donation and Transplantation in Belgium.
    J Med Virol. 2025;97:e70486.
    PubMed         Abstract available


    J Virol

  8. XU Z, Li L, Gu Y, Li D, et al
    CX1/BtSY2 and BANAL-20-52 exhibit broader receptor binding and higher affinities to multiple animal ACE2 orthologs than SARS-CoV-2 prototype.
    J Virol. 2025 Jul 10:e0028325. doi: 10.1128/jvi.00283.
    PubMed         Abstract available


    JAMA

  9. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
    The Failure of Life Expectancy to Fully Rebound to Prepandemic Levels.
    JAMA. 2025 Jul 9:e2510439. doi: 10.1001/jama.2025.10439.
    PubMed        

  10. STAR J, Bandi P
    Cancer Screening After the Onset of the COVID-19 Pandemic-Reply.
    JAMA. 2025 Jul 7. doi: 10.1001/jama.2025.6934.
    PubMed        

  11. WU G, Yin J, Huang Y
    Cancer Screening After the Onset of the COVID-19 Pandemic.
    JAMA. 2025 Jul 7. doi: 10.1001/jama.2025.6931.
    PubMed        

  12. RUBIN R
    The CDC No Longer Recommends COVID-19 Shots During Pregnancy-Now What?
    JAMA. 2025 Jul 11. doi: 10.1001/jama.2025.11889.
    PubMed        


    Lancet Infect Dis

  13. CHALKIAS S, Dennis P, Petersen D, Radhakrishnan K, et al
    Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial.
    Lancet Infect Dis. 2025 Jul 7:S1473-3099(25)00236.
    PubMed         Abstract available


    N Engl J Med

  14. PRASAD V, Makary MA
    An Evidence-Based Approach to Covid-19 Vaccination. Reply.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa6. doi: 10.1056/NEJMc2507760.
    PubMed        

  15. MEYEROWITZ EA
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa5. doi: 10.1056/NEJMc2507760.
    PubMed        

  16. DREKONJA D
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa4. doi: 10.1056/NEJMc2507760.
    PubMed        

  17. VOHRA-MILLER S, Marnik EA
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa3. doi: 10.1056/NEJMc2507760.
    PubMed        

  18. HAIDAR G, Hauschildt KE, Michaels MG
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa2. doi: 10.1056/NEJMc2507760.
    PubMed        

  19. PAPPAS G
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa1. doi: 10.1056/NEJMc2507760.
    PubMed        


    Nature

  20. TORTORICI MA, Choi A, Gibson CA, Lee J, et al
    Loss of FCoV-23 spike domain 0 enhances fusogenicity and entry kinetics.
    Nature. 2025 Jul 9. doi: 10.1038/s41586-025-09155.
    PubMed         Abstract available

  21. ATTIPA C, Warr AS, Epaminondas D, O'Shea M, et al
    Feline infectious peritonitis epizootic caused by a recombinant coronavirus.
    Nature. 2025 Jul 9. doi: 10.1038/s41586-025-09340.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

Stability of #influenza viruses in the #milk of #cows and #sheep

By G.M.
Abstract In late 2023, H5N1 high pathogenicity avian influenza (HPAIV) started circulating in dairy cattle in the USA . High viral titres were detected in milk from infected cows , raising concerns about onwards human infections . Although pasteurisation was shown to effectively inactivate influenza viruses in milk, unpasteurised milk still poses a risk of infection, both from occupational exposure in dairies and from the consumption of raw milk. We therefore assessed how long influenza viruses could remain infectious for in milk without heat inactivation. We examined the stability of a panel of influenza viruses in milk , including a contemporary H5N1 HPAIV and a variety of other influenza A and D viruses. We incubated viruses in cows' milk under laboratory conditions : at room temperature to simulate exposure in dairies and at 4°C to simulate exposure to refrigerated raw milk. Following an isolated report of H5N1 viral RNA being detected in milk from a sheep in the UK , we also c...
Post a Comment
Read more »

#Evidence of #Viremia in Dairy #Cows Naturally Infected with #Influenza A {#H5N1} Virus, #California, #USA

By G.M.
Abstract We confirmed influenza A virus (IAV) by PCR in serum from 18 cows on 3 affected dairy farms in California, USA . Our findings indicate the presence of viremia and might help explain IAV transmission dynamics and shedding patterns in cows. An understanding of those dynamics could enable development of IAV mitigation strategies. Source: US Centers for Disease Control and Prevention,  https://wwwnc.cdc.gov/eid/article/31/7/25-0134_article ____
Post a Comment
Read more »